MedPath

Using a State-wide Initiative to Disseminate Effective Behavioral Weight Loss Strategies: Study 5

Not Applicable
Completed
Conditions
Obesity
Registration Number
NCT02163252
Lead Sponsor
The Miriam Hospital
Brief Summary

The purpose of this study is to examine whether providing additional intervention support to individuals with lower than expected weight loss within the initial stages of an internet-based behavioral weight loss program improves weight loss outcomes at Week 12, compared to the internet program alone.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
110
Inclusion Criteria
  • age 18-70 years
  • BMI >=25 kg/m2
  • No health problems that make weight loss or unsupervised exercise unsafe
  • English speaking
  • Access to computer/internet
Exclusion Criteria
  • report a heart condition, chest pain during periods of activity or rest, or loss of consciousness on the Physical Activity Readiness Questionnaire 62 (PAR-Q; items 1-4).
  • Individuals endorsing joint problems, prescription medication use or other medical conditions that could limit exercise will be required to obtain written consent to participate from a health care provider
  • are currently pregnant or intend to become pregnant in the next 12 months
  • are planning to move outside of the state within the next 4 months

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change in weight12-week
Secondary Outcome Measures
NameTimeMethod
frequency of self-monitoring12 weeks

A secondary aim is to examine whether the provision of additional intervention support improves the frequency of self-monitoring as measured by the number of days that an individual logged their calorie information on the study website.

exercise minutes12 weeks

A secondary aim is to examine whether the provision of additional intervention support improves the number of exercise minutes reported each week, as logged by the individual on the study website.

Trial Locations

Locations (1)

The Miriam Hospital's Weight Control and Diabetes Research Center

🇺🇸

Providence, Rhode Island, United States

The Miriam Hospital's Weight Control and Diabetes Research Center
🇺🇸Providence, Rhode Island, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.